X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Genes & Diseases

期刊標題檢索 GENES DIS/Genes 最新評論: May 6 2024 Submit Jun 2 2024 With Editor Jun 16 2024 Under Revi... (2024-11-20)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Genes & Diseases]您好,您是該頁面的第 49752 位訪客。

期刊簡介
期刊名稱Genes & Diseases Genes & Diseases
LetPub Score
7.0
50 ratings
Rate

Reputation
8.8

Influence
5.7

Speed
7.0

期刊簡稱GENES DIS/Genes and Diseases
ISSN2352-4820
E-ISSN2352-3042
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.301.4461.228
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Genetics (clinical)
Q122 / 99
Category: Medicine
Subcategory: Biochemistry
Q2129 / 438
Category: Medicine
Subcategory: Molecular Biology
Q2150 / 410
Category: Medicine
Subcategory: Cell Biology
Q2118 / 285

自引率 (2023-2024)2.90%自引率趨勢
掲載範囲
Genes & Diseases is an international journal for molecular and translational medicine. The journal primarily focuses on publishing investigations on the molecular bases and experimental therapeutics of human diseases. Publication formats include full length research article, review article, short communication, correspondence, perspectives, commentary, views on news, and research watch.

Aims and Scopes

Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis will be placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
官方網站https://www.journals.elsevier.com/genes-and-diseases
在線稿件提交https://www.editorialmanager.com/GENDIS
開放訪問Yes
出版商ELSEVIER
主題領域Multiple
出版國/地區PEOPLES R CHINA
發行頻率四半期刊行
創刊年2014
每年文章數153每年文章數趨勢
黃金OA百分比98.63%
OA Related Info
APC: Yes( USD2500; )
APC waiver:No
Other charges: No
Keywords: molecular genetics、cell biology、stem cell biology、gene regulation and epigenetics、immunity and infection、neuroscience
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ136/313
GENETICS & HEREDITYSCIEQ116/191
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2352-4820%5BISSN%5D
平均審稿時間 *來自出版商的數據: Time to First Decision: 2.3 weeks; Review Time: 3.7 weeks; Publication Time: 1.6 weeks;
來自作者的數據: 50 Weeks
競爭力 *來自作者的數據: 14%
來自Elsevier的數據: 14%
參考鏈接
相關期刊 【Genes & Diseases】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE645740
    BIOMATERIALS601406
    Frontiers in Pharmacology504180
    BIOMEDICINE & PHARMACOTHERAPY498667
    JOURNAL OF ETHNOPHARMACOLOGY497025
    Journal of Materials Chemistry B476183
    Frontiers in Immunology461447
    COMPUTERS IN BIOLOGY AND MEDICINE420858
    COLLOIDS AND SURFACES B-BIOINTERFACES419559
    Frontiers in Oncology415908
  •  

    Genes & Diseases Genes & Diseases
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Genes & Diseases] 的評論撰寫評論
作者: 雨润平江


領域: 医学
審稿時間: 6.0 month(s)
結果: 拒稿


撰寫評論

2024-11-20 17:49:51 評論於
May 6 2024 Submit
Jun 2 2024 With Editor
Jun 16 2024 Under Review
Sep 26 2024 Decision in Process
Nov 17 2024 Requested to resubmit as a short communication.
It's frustrating to have to wait so long, but what's even more irritating is the statement: "We completed the peer review process of your manuscript." Six months, who has ever heard of a six-month peer review process?
(0) 讚! | 雨润平江

作者: Dr. Wang


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2023-08-30 19:44:04 評論於
Hope gets better and better
(1) 讚! | Dr. Wang

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Genes & Diseases] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*